Korea Trying To Carve Out Large Share of Early-Stage Clinical Trial Work In Asia - Bio Korea 2010
This article was originally published in The Pink Sheet Daily
Executive Summary
The reasons to come to Asia are high disease prevalence, clinical expertise and a vibrant R&D environment, but capitalizing on each country's strengths is the key to success, according to J&J Senior Director, Asia Pacific Global Clinical Operations, Aakash Ganju,.